INTRODUCTION
============

Contraction of the actomyosin cytoskeleton drives cell and tissue movements during morphogenesis ([@B91]; [@B26]) and wound closure ([@B82]), and allows cells to perceive and respond to mechanical stress ([@B15]). In nonmuscle cells, cell contraction is driven by the interaction of the motor protein nonmuscle myosin II (NMII) with filamentous actin. NMII is activated by phosphorylation on its myosin regulatory light-chain subunits (MRLC; [@B87]). Upon MRLC phosphorylation, myosin forms bipolar filaments and becomes catalytically active ([@B17]; [@B107]). In mammalian cells, MRLC can be phosphorylated at Thr-18 and Ser-19 by several kinases, including myosin light-chain kinase (MLCK) ([@B83]; [@B28]; [@B70]) and Rho kinase (ROCK) ([@B1]; [@B22]; [@B4]) and is dephosphorylated by myosin phosphatase (MYPT) ([@B39]) so that the level of p-MRLC in different tissues is determined by the balance of kinase and phosphatase activities ([@B41]).

In addition to its role in nonmuscle cells, MLCK regulates contractility in skeletal muscle, cardiac muscle, and smooth muscle cells ([@B17]; [@B107]; [@B30]; [@B120]). In humans, MLCK is encoded by four genes, *MYLK1--4*, that produce tissue-specific kinases with well-conserved kinase domains ([@B41]; [@B12]). *MYLK1* is the best characterized of the four MLCKs and encodes multiple isoforms, including smooth muscle myosin light-chain kinase (smMLCK) ([@B54]). Mutations in *MYLK* are associated with aortic aneurysms ([@B109]), inflammatory bowel disease ([@B18]), asthma ([@B2]; [@B20]; [@B62]; [@B111]), and sepsis ([@B23]). Proper MLCK function is therefore critical to the function of many contractile cell types.

Vertebrate MLCK contains a bilobate kinase domain that is inhibited by a short autoinhibitory or regulatory domain under low-Ca^2+^ conditions. Upon Ca^2+^/calmodulin (CaM) binding, autoinhibition is relieved, and the two lobes of the kinase rotate and close to facilitate ATP hydrolysis and MRLC phosphorylation ([@B48]; [@B73]; [@B49]; [@B99]). The structural domains and kinetics of MLCK have been studied well in vitro (reviewed in [@B99]; [@B30]) and in cell culture and ex vivo systems ([@B108]; [@B38]; [@B82]). Additionally, mammalian in vivo systems do not allow easy visualization of contractile tissue function in intact animals, limiting the ability to study the role of MLCKs in actomyosin contractility in real time.

*Caenorhabditis elegans* is small and transparent, allowing visualization of tissues in intact animals. The *C. elegans* gonad is an excellent in vivo model for the regulation of contraction in real time. Each hermaphrodite has two U-shaped gonad arms, surrounded by smooth-muscle-like sheath cells, which contract to ovulate mature oocytes into the spermatheca, where the oocyte is fertilized ([@B98]; [@B63]; [@B36]). The spermatheca is made up of 24 myoepithelial cells that contract in coordination to propel the fertilized embryo into the uterus during ovulation ([@B98]; [@B64]). Ovulation occurs ∼150 times per gonad arm during the reproductive lifespan of the animal ([@B29]).

Two pathways, a calcium-dependent pathway ([@B42]; [@B52]) and a Rho-regulated pathway ([@B116], [@B115]; [@B25]; [@B102]), are needed for contraction of the spermatheca. Rho regulates the degree of contraction and the timing of embryo transit through the spermatheca ([@B102]). The Rho kinase (ROCK/LET-502) regulates sheath cell contractility in *C. elegans* ([@B115]; [@B75]). In addition to phosphorylating MRLC, the Rho kinase ROCK elevates myosin activity by phosphorylating and inactivating myosin phosphatase ([@B44]). Because ROCK/LET-502 is expressed primarily in the distal neck of the spermatheca and the spermatheca--uterine (sp-ut) valve ([@B115]), we hypothesized that an as yet unidentified MLCK might, in coordination with ROCK, regulate spermathecal contraction through phosphorylation of the MRLC.

In this study, we performed a candidate RNA interference (RNAi) screen to identify the kinase or kinases that might phosphorylate and activate myosin in the *C. elegans* spermatheca. We identified a previously uncharacterized gene, *ZC373.4/mlck-1*, that is required for contractility of the spermatheca. We show that loss of *mlck-1* results in a failure of oocytes to exit the spermatheca and demonstrate that MRLC phosphorylation in the spermatheca depends on MLCK-1. MLCK-1 is also recruited to, and required for, maintenance of proper actomyosin bundles and dynamics. In addition to the role of MLCK-1 in phosphorylating the MRLC, we found that ROCK/LET-502 regulates MRLC phosphorylation in a subset of cells. Together, these two kinases coordinate spermathecal transit in the *C. elegans* spermatheca.

RESULTS
=======

MLCK-1 is a putative myosin light-chain kinase required for spermathecal contractility
--------------------------------------------------------------------------------------

To identify potential kinases regulating spermathecal contractility, we performed a candidate RNAi screen. We screened *C. elegans* homologues of kinases that have previously been shown to phosphorylate MRLCs, including putative and known myosin light-chain kinases: ROCK ([@B1]), citron kinase ([@B117]), myotonic dystrophy--related CDC42-binding kinase (MRCK) ([@B59]), zipper- interacting protein kinase (ZIPK) ([@B69]), and death-associated protein kinase (DAPK) ([@B90]). We also screened several kinases that have been shown to have activity toward MRLC in *C. elegans*, including UNC-89 ([@B95]), titin/TTN-1 ([@B19]), and twitchin/UNC-22 ([@B68]; [@B5]). Additionally, we screened 11 other genes that had kinase domains similar to those of human MLCK, identified using the basic local alignment search tool (BLAST). To avoid disrupting embryonic development, animals were fed RNAi after hatching and scored for spermathecal contractility defects as adults. We have shown previously that disruption of spermathecal contractility can result in accumulation of one or more embryos in the spermatheca ([@B51]). Animals that are mutants for the phospholipase *plc-1*, which is required for Ca^2+^ release in the spermatheca, display this phenotype ([@B52]). We hypothesized that loss of the kinase that activates myosin in the spermatheca would result in comparable spermathecal contractility defects. Similarly to loss of *plc-1*, we found that knockdown of *ZC373.4* significantly increases the percentage of spermathecae occupied by one or more embryos ([Figure 1](#F1){ref-type="fig"}). Because ZC373.4, renamed MLCK-1, is the only kinase that displayed a strong defect in spermathecal contractility similar to that for *plc-1*, here we focus on characterizing the role of *mlck-1* in spermathecal function.

![MLCK-1 is required for oocyte transit through the spermatheca. Wild-type animals were grown on empty vector (control), *plc-1* (positive control), or candidate myosin kinase RNAi and scored as young adults for spermathecal occupancy in the following categories: unoccupied, occupied with a single embryo, more than one embryo, a small piece of embryo, or no entry, where oocytes fail to enter the spermatheca. MLCK-1 is required for WT ratios of occupied vs. unoccupied spermathecae. Statistics were performed for the total number of unoccupied spermathecae compared with the sum all other phenotypes. *N* is the total number of spermathecae counted. Fisher's exact test: \*\*\*\**p* \< 0.0001, \*\**p* ≤ 0.01.](mbc-29-1975-g001){#F1}

MLCK-1 is structurally similar to human MLCK
--------------------------------------------

The *mlck-1* gene is ∼7 kb and is predicted to encode a single 1211--amino acid protein with a kinase domain and an adjacent C-terminal 1-8-14 calmodulin binding domain ([Figure 2, A--C](#F2){ref-type="fig"}; [@B119]). Additionally, the C-terminal end of the putative kinase domain contains a conserved HPW helix insertion, a complete linker sequence, and an autoregulatory helix with the three conserved hydrophobic residues necessary to anchor the autoregulatory helix to the kinase core in the absence of Ca^2+^/CaM binding (Supplemental Figure 1A; [@B12]). The location of the C-terminal CaM binding domain suggests that CaM binding might relieve autoinhibition and permit MLCK binding and phosphorylation of MRLC ([@B7]). Additionally, MLCK-1 shares 50.2% homology in its kinase domain with *Homo sapiens* smMLCK (Uniprot ID Q15746; ([@B35]; Supplemental Figure 1B; [Figure 2D](#F2){ref-type="fig"}). All four human MLCK protein kinase domains are structurally similar and show levels of homology similar to those for MLCK-1 (Supplemental Figure 1B). The predicted three-dimensional (3D) structures of the kinase domains are highly conserved ([@B121]; [@B81]; [@B118]). Both have the glutamate residues, which bind the MRLC in the uninhibited conformation, and the active sites in similar locations ([Figure 2D](#F2){ref-type="fig"}; [@B27]; [@B21]). MLCKs are known as dedicated kinases of the MRLC. This specificity is thought to be due to MRLC's hydrophobic residues in the P+1, P+2, P+3, and P-3 positions ([@B99]) relative to the phosphorylatable serine, which are conserved in human and *C. elegans* MRLCs (Supplemental Figure 1C). Therefore, bioinformatic analysis suggests that MLCK-1 may act as a Ca^2+^/CaM--responsive myosin light-chain kinase.

![MLCK-1 has a serine/threonine kinase domain that is structurally similar to that in human MLCKs. (A) The *mlck-1* gene spans ∼7 kb and is made up of 22 exons. The positions of two RNAi targeting constructs (A, B) and the *tm4159* deletion are labeled. (B) MLCK-1 has an N-terminal kinase domain (pink), with its active site and ATP binding domain labeled in yellow and green, respectively. Putative calmodulin binding domains are labeled in blue. (C) MLCK-1 contains a putative 1-8-14 Ca^2+^-dependent calmodulin binding domain homologous to smMLCK. (D)The kinase domain--predicted structures (iTasser) are similar. Key glutamate residues (red) bind the RLC substrate. The active site aspartate residue is in green.](mbc-29-1975-g002){#F2}

MLCK-1 is expressed in the spermatheca and is localized to contractile actomyosin bundles during contraction
------------------------------------------------------------------------------------------------------------

To characterize the MLCK-1 expression pattern, we generated a GFP-promoter transcriptional reporter and a CRISPR line in which the endogenous *mlck-1* locus is labeled at the C-terminus with mKate2. The two lines displayed overlapping but not identical expression patterns ([Figure 3](#F3){ref-type="fig"} and Supplemental Figure 2). The transcriptional reporter line exhibited strong MLCK-1 expression in the pharynx, anal sphincter, vulval cells, spermatheca, and sp-ut valve (Supplemental Figure 2A), while the CRISPR line showed MLCK-1 expression in the pharynx, uterus, spermatheca, and sp-ut valve ([Figure 3A](#F3){ref-type="fig"}). Importantly, both lines show expression in the spermatheca. There are no apparent phenotypes in the CRIPSR-tagged line, indicating that the MLCK-1::mKate2 fusion is likely functional (Supplemental Movie 1; Supplemental Figure 2B).

![MLCK-1 is expressed in the *C. elegans* spermatheca and localizes to apical cell boundaries and basal actin bundles. (A) Confocal images of animals from L4 to young adult expressing MLCK-1 tagged with mKate2 at the endogenous locus. MLCK-1 expression is seen in the spermatheca throughout development. (B) Magnified maximum-intensity projections of the spermathecae from the animals in A indicated with dashed boxes. The Fire color scale is used to highlight changes in fluorescence intensity. MLCK-1 expression increases from L4 to young adulthood and is primarily localized apically. In mature adults, a subpopulation of MLCK-1 is observed at the basal surface. (C) Confocal images of a spermatheca after the first ovulation from an animal coexpressing MLCK-1::mKate2 (red) and AJM-1::GFP (blue), which localizes near the apical surface of the spermathecal cells. Maximum-intensity projections show the proximity of MLCK-1 and AJM-1, with MLCK-1 immediately apical to AJM-1. The insert is a magnified cross-section from the area indicated with a dashed line, with basal at the bottom. (D) Confocal images of a WT excised spermatheca after the first ovulation expressing MLCK-1::mKate2 and stained with phalloidin to visualize F-actin. Maximum-intensity projections show actin bundles and MLCK-1 localization. The cross-section shows that prominent actin bundles are basal and a small population of MLCK-1 colocalizes with these bundles. Inserts are a magnified cross-section of the area indicated with a dashed line. Basal is at the bottom. Note that the brightness in the insert in D is enhanced to facilitate simultaneous visualization of thick basal actin bundles and the thin apical actin network. (E) Quantification of a line scan drawn across the apical cell surface in the area indicated by the insert in C. The fluorescence peak for AJM-1::GFP is just basal to MLCK-1::mKate2 peak. (F) Quantification of a line scan drawn across the area indicated in the insert in (D) from the basal to the apical cell surface. The majority of the MLCK-1::mKate2 signal is apical and a small peak aligns with the basal fluorescence peak for F-actin. Scale bar, 100 μm in A, 20 μm in B--D, and 5 μm in the inserts in C and D. Ap., apical; Bs., basal.](mbc-29-1975-g003){#F3}

###### Movie S1

MLCK-1 is recruited to basal actomyosin bundles during contraction in a PLC-1 dependent manner. Maximum intensity projections of a confocal 4-D ovulation movie of animals expressing MLCK-1::mKate2 treated with control (top) or plc-1 RNAi (bottom). In spermathecae of both wild type and plc-1(RNAi) animals, MLCK-1 is focused at apical cell boundaries prior to oocyte entry when the distal spermathecal neck first opens (0 s) and after the oocyte is completely within the spermathecae (100 s). In the wild type spermatheca, a subset of MLCK-1 diffuses away from cell boundaries during contraction (480 s) and remains there after oocyte exit (690 s). In the plc-1(RNAi) spermatheca, the embryo is retained in the spermatheca and MLCK-1::mKate2 remains exclusively at cell boundaries throughout the duration of imaging (1390 s). Ovulation was recorded by acquiring 20 confocal z-slices every 10 seconds and the frame rate of the movie is 10 frames per second. Scale bar is 20 μm.

Movie S1

By mid L4, faint MLCK-1 expression is evident in the cells of the developing spermatheca. Expression levels peak in adulthood ([Figure 3B](#F3){ref-type="fig"}). During L4, MLCK-1 is localized to apical boundaries of the spermathecal cells ([Figure 3, B and C](#F3){ref-type="fig"}), which face the lumen of the spermathecal bag. In adults, MLCK-1 is localized both apically and basally in the spermatheca ([Figure 3B](#F3){ref-type="fig"}). We have previously shown that active myosin is recruited to basal actomyosin bundles concomitant with spermathecal contraction ([@B114]). Therefore, we anticipated that MLCK-1 would colocalize with its putative substrate, MLC-4, in these actomyosin bundles. To visualize the localization of the basal population of MLCK-1, gonads were excised from the labeled *mlck-1::mKate2*--expressing animals, and phalloidin was used to visualize F-actin. As expected, we observed thick bundles of actin at the outer, basal surface with a thinner actin network visible at the apical surface ([Figure 3, D and F](#F3){ref-type="fig"}). MLCK-1 fluorescence intensity is brightest at the apical boundaries ([Figure 3, C and E](#F3){ref-type="fig"}). However, some MLCK-1 is also localized to the basal cell surface, where it partially colocalizes with the contractile actomyosin bundles ([Figure 3, D and F](#F3){ref-type="fig"}; Supplemental Figure 4).

To determine whether the basal recruitment of MLCK-1 seen in adults requires ovulation and *plc-1*, we repeated the experiment on control and *plc-1(RNAi)* animals before and after the first ovulation. In spermathecae of control animals, MLCK-1::mKate2 fluorescence becomes visible at the basal cell surface after the first ovulation. In contrast, in spermathecae of *plc-1(RNAi)* animals, there is no significant increase MLCK-1 at the basal cell surface after ovulation ([Figure 4, A--C](#F4){ref-type="fig"}). To understand when MLCK-1 localization changes during ovulation and to determine what drives MLCK-1 dynamics, we used four-dimensional (4D) confocal microscopy of live animals to capture time-lapse videos of ovulation. Before the first ovulation, MLCK-1 is restricted to apical boundaries ([Figure 4, D--G](#F4){ref-type="fig"}). During oocyte entry, the spermatheca is stretched. However, this initial cell stretch is not sufficient to displace MLCK-1 from the apical boundaries because MLCK-1 localization remains unchanged until ∼350 s after oocyte entry ([Figure 4A](#F4){ref-type="fig"}). MLCK-1 begins to move basally as the spermathecal cells contract and the embryo is expelled from the spermatheca, ∼480 s after opening of the distal neck ([Figure 4](#F4){ref-type="fig"}). This partial relocalization of MLCK-1 to the basal surface is maintained throughout adulthood. In animals depleted of *plc-1*, the oocyte enters the spermatheca but becomes trapped as spermathecal cells fail to contract ([@B52]). In these animals, MLCK-1 is retained at apical boundaries ([Figure 4, D--G](#F4){ref-type="fig"}). These results suggest Ca^2+^ signaling may play a role in the initiation of contraction and the movement of MLCK-1 away from the apical boundaries.

![MLCK-1 is recruited basally during contraction in a PLC-1--dependent manner. (A) Confocal maximum-intensity projections of excised spermathecae from WT and *plc-1(RNAi)* animals before and after the first ovulation. Inserts are a magnified cross-section of the area indicated in A with a dashed line. Fluorescence intensity is increased in inserts to highlight the subset of basally located MLCK-1 present in spermathecae after the first ovulation, which is absent in *plc-1(RNAi)* spermathecae. White arrowheads indicate basal cell surface. (B) Quantification of MLCK-1::mKate2 fluorescence intensity across the cross-section shown in the inserts in A. (C) Fluorescence intensity at the basal cell surface measured from 14 WT spermathecae before the first ovulation, 30 after the first ovulation, 6 *plc-1*(RNAi) spermathecae before the first ovulation, and 7 after the first ovulation. (D) Still frames from a confocal 4D ovulation movie of animals expressing MLCK-1::mKate2 treated with control (WT) or *plc-1* RNAi. In spermathecae of both WT and *plc-1(RNAi)* animals, MLCK-1 is localized to the apical surface of the spermatheca prior to oocyte entry when the distal spermathecal neck first opens (0 s) and after the oocyte is completely within the spermathecae (100 s). In WT spermathecae, a subset of MLCK-1 diffuses away from apical boundaries during contraction (480 s) and is retained basally even after oocyte exit (690 s). (E, F) Quantification of MLCK-1::mKate2 fluorescence intensity across a single cell, indicated by a dashed line in D, at 100 and 480 s for the WT (E) and *plc-1(RNAi)* (F) spermathecae. The peaks indicate MLCK-1 localized at cell boundaries. By 480 s, fluorescence intensity between the peaks increases in the WT cell (E). This is not seen in the *plc-1(RNAi)* cell (F). (G) Quantification of the average MLCK-1::mKate2 fluorescence intensity measured across the cell center, excluding MLCK-1 localized to cell boundaries, during ovulation. MLCK-1::mKate2 fluorescence is first detected at 350 s and increases during contraction in WT cells but not *plc-1(RNAi)* cells. Measurements were taken of individual cells from three different first ovulation movies for WT (nine cells total) and *plc-1(RNAi)* (nine cells total) animals at 50 s intervals. No more than three cells were measured from the same animal. Error bars represent SEM. Error bars indicated SEM. Unpaired *t* test: ns *p* \> 0.05; \*\*\*\**p* ≤ 0.0001. Scale bar, 20 μm and 5 μm for inserts. Ap., apical; Bs., basal.](mbc-29-1975-g004){#F4}

MLCK-1 is required maternally for fertility
-------------------------------------------

Disruption of genes required for regulating spermatheca contractility can result in the production of fewer live offspring ([@B51]; [@B52]). To test for fertility defects in *mlck-1* loss of function, we used the hypomorphic allele *mlck-1*(*tm4159*) and two different *mlck-1* RNAi clones that targeted distinct regions of the gene to disrupt MLCK-1 function ([Figure 2A](#F2){ref-type="fig"}). The allele has a 514--base pair deletion that leaves the kinase domain intact ([Figure 2A](#F2){ref-type="fig"}), while the RNAi depletes *mlck-1* below detectable levels (Supplemental Figure 3). The *tm4159* allele is temperature-sensitive, perhaps because of instability of the encoded protein ([@B105]; [@B9]; [@B24]). The *tm4159* animals grown at 25°C produce only a few live hatchlings. *tm4159* animals grown at 23°C also produce significantly fewer live offspring than wild-type (WT) animals grown at the same temperature, while worms reared at 15°C produce WT numbers of live offspring ([Figure 5A](#F5){ref-type="fig"}). Treatment with either of two nonoverlapping *mlck-1* RNAi clones also resulted in significantly fewer live offspring ([Figure 5B](#F5){ref-type="fig"}).

![MLCK-1 is required for fertility. (A) The *mlck-1(tm4159)* allele is temperature-sensitive and results in a reduction in number of live offspring. This reduction is more severe at higher temperatures. Each data point reflects the number of live F1 offspring from one individual. Error bars indicate SEM. Unpaired *t* test: \*\*\*\**p* \< 0.0001. (B) Depletion of *mlck-1* using two RNAi clones that target distinct regions of the *mlck-1* gene results in a significant reduction in numbers of live offspring compared with animals fed control RNAi. Error bars indicate SEM. One-way ANOVA with Dunnett's multiple comparison test: \*\*\*\**p* \< 0.0001, \*\**p* ≤ 0.01.](mbc-29-1975-g005){#F5}

To determine whether *mlck-1* is required for embryonic development, we tracked the hatching of embryos from *mlck-1* mothers at 23°C. We find that 18% of *mlck-1(tm4159)* embryos fail to hatch (*n* = 551) compared with only 2% of WT embryos (*n* = 821). This suggests a modest reduction in embryonic viability in *mlck-1(tm4159)* animals, which is insufficient to explain the observed reduction in live offspring (Supplemental Figure 5A). To explore the possibility *tm4159* has a maternal effect, we mated *mlck-1(tm4159)* hermaphrodites with WT males and found that the paternally inherited WT *mlck-1* allele is insufficient to rescue the reduction in numbers of live offspring (Supplemental Figure 5B). Conversely, when a WT hermaphrodite is crossed with a *mlck-1(tm4159)* male, the embryos are viable and WT numbers of offspring are observed (Supplemental Figure 5, A and B). This demonstrates that *mlck-1*/+ heterozygous offspring are viable and that *mlck-1* is not required in sperm. Taken together, these results suggest that *mlck-1* depletion reduces numbers of live offspring and embryonic viability through a maternal mechanism.

MLCK-1 is required for contraction of the spermatheca
-----------------------------------------------------

We next hypothesized that MLCK-1 may be required for contraction of the spermatheca and exit of the newly fertilized embryo into the uterus. To characterize the temperature sensitivity of transit defects in *mlck-1(tm4159)* animals, we performed an occupancy assay as described above on wild-type and *mlck-1(tm4159)* animals reared at 15, 23, or 25°C. Spermathecal contractility defects are more pronounced at the warmer temperatures, and animals grown at 23 and 25°C have a higher percentage of spermathecae occupied with multiple embryos (Supplemental Figure 5C). These results are in agreement with our *mlck-1(RNAi)* data ([Figure 1](#F1){ref-type="fig"}), indicating that depletion of *mlck-1* via RNAi or the *mlck-1(tm4159)* allele at 25°C produces similar results. To determine how spermathecal contraction is altered in real time, we imaged full ovulations of WT animals and animals depleted of *mlck-1* via RNAi or the *mlck-1(tm4159)* allele (Supplemental Movies 2 and 3; [Figure 6A](#F6){ref-type="fig"}). Three aspects of oocyte transit were quantified: entry time, dwell time, and exit time.

![MLCK-1 is required for contractility of the spermathecal bag cells. (A) Stills from time-lapse imaging of animals fed either control or *mlck-1* RNAi, respectively. Embryos from hermaphrodites fed *mlck-1* RNAi fail to exit the spermatheca. The spermatheca is outlined in either blue or red for animals fed control and *mlck-1* (A) RNAi, respectively. Scale bar = 10 μm. (B) No significant difference in entry time is observed. One-way ANOVA with Tukey's multiple comparison test. ns *p* \> 0.05. (C) Dwell time in WT animals fed control RNAi is 218 ± 58.9 s (*n* = 12). In animals fed *mlck-1* RNAi, 9 out of 11 ovulations imaged had indefinite dwell times. There is no significant difference between WT animals grown at 23°C and fed control RNAi and WT animals grown at 25°C and fed OP50. One hundred percent of *mlck-1(tm4159)* nematodes (*n* = 6) grown at the nonpermissive temperature, 25°C, fail to exit the spermatheca during the time imaged (\>950 s). Error bars indicate SEM. One-way ANOVA with Tukey's multiple comparison test: ns *p* \> 0.05, \**p* ≤ 0.05, \*\*\**p* ≤ 0.001. (D) Animals competent for RNAi in the spermatheca only fed *mlck-1* RNAi have a significant number of spermathecae occupied compared with wild type. Fisher's exact test (nonoccupied vs. all other outcomes): \*\*\*\**p* \< 0.0001.](mbc-29-1975-g006){#F6}

###### Movie S2

DIC movie of a wild type ovulation. The sheath contracts and the oocyte is squeezed into the spermatheca bag beginning at approximately 30sec. The oocyte remains in the spermatheca for several minutes until the sp-ut valve opens at approximately 4 minutes 30 seconds. The fertilized embryo is then pushed into the uterus through spermathecal contractions. Images were acquired at 1 image per second. Playback is 60 frames per second. Scale bar is 10μm.

Movie S2

###### Movie S3

Depletion of mlck-1 results in embryos being trapped in the spermatheca. Contractions from the sheath cells coordinate with the distal neck to push the oocyte into the spermatheca bag. The oocyte is fertilized, but the spermatheca fails to contract and the embryo begins to develop and divide within the spermatheca for the length of imaging (\>55 minutes). Images were acquired at 1 image per second. Playback is 60 frames per second. Scale bar is 10μm.

Movie S3

Entry time describes the time from the beginning of oocyte entry to when the distal neck cells close around the now fertilized embryo. Entry requires coordination between the proximal gonadal sheath cells and spermathecal distal neck cells. Loss of *mlck-1* using either RNAi or the *mlck-1(tm4159)* allele at 25°C does not significantly slow entry time ([Figure 6B](#F6){ref-type="fig"}). This result suggests that MLCK-1 may not play a critical role in sheath cell contraction.

Dwell time refers to the time between closure of the distal neck and the opening of the sp-ut valve. This is the amount of time that the embryo is completely enclosed by the spermatheca. Knockdown of *mlck-1* with RNAi generally results in failure of embryos to exit the spermatheca (77%, *n* = 9; Supplemental Movie 3; [Figure 6C](#F6){ref-type="fig"}; Supplemental Figure 6A). Occasionally, an *mlck-1(RNAi)* animal exhibits a successful transit, which may be due to variability in RNAi penetrance. In *mlck-1(tm4159)* animals grown at 25°C, oocytes enter the spermatheca but become trapped as the spermatheca fails to contract (100%, *n* = 6; [Figure 6C](#F6){ref-type="fig"}). Trapping can result from defective sp-ut valve dilation. To address this, we constructed a spermathecal-specific RNAi strain. In this strain, *rde-1*, an Argonaute required for RNAi ([@B100]), is rescued only in the spermathecal bag using the *fkh-6* promoter ([@B33]). When we deplete *mlck-1* in the spermathecal bag, leaving the sp-ut valve functional, embryos fail to exit properly ([Figure 6D](#F6){ref-type="fig"}). This suggests that MLCK-1 in the spermathecal bag cells is needed for successful embryo exit.

The last metric we used is exit time, the time from the dilation of the spermatheca uterine valve to when the embryo has been pushed into the uterus and the sp-ut valve has fully reclosed. Although we cannot measure exit time when embryos become trapped in the spermatheca, as is seen in *mlck-1(RNAi)* and *mlck-1(tm4159)* animals at 25°C, *mlck-1(tm4159)* animals grown at 23°C exhibit significantly slower exits than WT animals (Supplemental Figure 6C). Taken together, these results suggest that MLCK-1 is required in the spermathecal bag cells, and that transit defects are mainly due to a decrease in spermathecal cell contractility and a failure to push the fertilized embryo out through the sp-ut valve and into the uterus.

MLCK-1 is required for production of p-MRLC in the spermatheca
--------------------------------------------------------------

We hypothesized that transit defects in *mlck-1* animals were due to failure to phosphorylate the MRLC during ovulation to activate myosin and initiate cell contraction. To determine the contribution of MLCK-1 to p-MRLC production in the spermatheca, we used immunohistochemistry to quantify p-MRLC levels ([Figure 7](#F7){ref-type="fig"}). To confirm that our antibody accurately reports p-MRLC levels, we included *mel-11(RNAi)* and *mlc-4(RNAi)* spermathecae as controls. MEL-11 is the *C. elegans* ortholog of the myosin-associated phosphatase regulatory subunit (referred to here as myosin phosphatase) required to dephosphorylate MRLC during cell relaxation ([@B115]; [@B52]; [@B75]; [@B114]). As expected, quantification of p-MRLC levels in *mel-11(RNAi)* spermathecal cells reveals that these cells have significantly elevated p-MRLC, compared with unoccupied WT spermatheca ([Figure 7](#F7){ref-type="fig"}). MLC-4 is the only *C. elegans* nonmuscle MRLC ([@B89]). As anticipated, we find that *mlc-4(RNAi)* spermathecal cells have very low levels of p-MRLC ([Figure 7](#F7){ref-type="fig"}).

![MLCK-1 is required for pMRLC production in the spermatheca. (A) Quantification of pMRLC levels detected using a pMRLC-specific antibody. Measurements were taken from 37 WT unoccupied, 11 WT occupied, 53 *mlck-1(RNAi),* 35 *mel-11(RNAi),* and 28 *mlc-4(RNAi)* spermathecal cells with no more than three cells measured from the same animal. Dunnett's multiple comparison test: ns *p* \> 0.05, \**p* ≤ 0.05, \*\**p* ≤ 0.01, \*\*\*\**p* ≤ 0.0001. Error bars represent SD. (B) Representative confocal maximum intensity projections of the data presented in (A) F-actin was stained using phalloidin to detect individual cells. An example cell is outlined in the image, showing actin and pMRLC levels. Numbers are the total fluorescence intensity values of the selected cells. Scale bar, 20 μm.](mbc-29-1975-g007){#F7}

Comparison of p-MRLC levels in cells from unoccupied and occupied WT spermathecae reveals that occupied spermathecae tend to have higher p-MRLC levels ([Figure 7](#F7){ref-type="fig"}). This suggests that p-MRLC levels may peak during ovulation. By comparison, cells of *mlck-1(RNAi)* spermathecae consistently have low p-MRLC levels ([Figure 7](#F7){ref-type="fig"}). Even though all *mlck-1(RNAi)* spermathecal cells observed are from occupied spermathecae, these cells fail to achieve the peak p-MRLC levels seen in WT occupied spermathecae ([Figure 7](#F7){ref-type="fig"}). In *mlck-1(RNAi)* spermatheca, only very low levels of p-MRLC can be seen at cell boundaries, while p-MRLC was detected at cell boundaries and throughout the cytosol in WT occupied spermatheca ([Figure 7](#F7){ref-type="fig"}). p-MRLC levels in *mlck-1(RNAi)* and *mlc-4(RNAi)* spermathecal cells are not significantly different. In summary, we find that MLCK-1 is required for the production of peak p-MRLC levels during ovulation and that loss of *mlck-1* results in reduced p-MRLC levels comparable to those from directly depleting MRLC.

MLCK-1 is required for development of parallel actomyosin bundles during ovulation
----------------------------------------------------------------------------------

During spermathecal cell contraction, the actomyosin cytoskeleton reorganizes from an isotropic interconnected network to form highly organized, basal, parallel actomyosin bundles ([@B114]). Myosin activity plays a key role in spermathecal cell contractility and organization of these basal actomyosin bundles ([@B114]). Because MLCK-1 is required for spermathecal contractility and myosin activity, we hypothesized that MLCK-1 would also be required for WT actomyosin network organization. To determine the role of MLCK-1 in actomyosin bundle formation during ovulation, we used 4D confocal microscopy of live animals expressing GFP::ACT-1 driven by a spermathecal specific promoter to observe actin dynamics during ovulation. Actin network organization was quantified using the ImageJ plug-in FibrilTool ([@B8]) to measure anisotropy. As previously reported, production of parallel actin bundles in WT spermathecal cells occurs after cell stretch due to oocyte entry and coincides with the onset of contraction ([Figure 8, A and A](#F8){ref-type="fig"}'). In contrast, *mlck-1(RNAi)* spermathecal cells fail to produce WT actomyosin bundles. Instead, thin tortuous bundles that frequently fail to extend the whole length of the cell are present even after lengthy cell stretch ([Figure 8](#F8){ref-type="fig"}). Simultaneous visualization of F-actin (moe-ABD::mCherry) and myosin (GFP::NMY-1) reveals that actin and myosin colocalize into parallel actomyosin bundles in WT spermathecae ([Figure 8, B--E](#F8){ref-type="fig"}). Without *mlck-1*, myosin is poorly recruited to the basal actin bundles and a large fraction of myosin remains diffused throughout the cytosol ([Figure 8, B--E](#F8){ref-type="fig"}). This indicates that MLCK-1 is required for production of the basally enriched parallel actomyosin bundles.

![MLCK-1 is required for formation of actomyosin bundles. (A) Quantification of anisotropy (degree of alignment) in individual spermathecal cells expressing GFP::ACT-1 to label actin during ovulation. FibrilTool was used to measure anisotropy in individual cells at 28-s intervals during ovulation. No more than two cells were measured from the same animal. For WT, *n* = 14 cells (7 animals); for *mlck-1(RNAi)*, *n* = 6 cells (3 animals). (A') Representative confocal maximum-intensity projections of spermathecal cells expressing GFP labeled actin before (112 s) and after (1092 s) development of actomyosin bundles analyzed in A. Each cell is outlined with a dotted line and OrientationJ was used to false color actin bundles according to their orientation. (B) Confocal maximum intensity projections of spermathecae expressing moeABD::mCherry to label F-actin and GFP::NMY-1 to label myosin. Note that myosin appears diffuse and is poorly recruited to actin bundles in the *mlck-1(RNAi)* spermatheca. (C, D) Fluorescence intensity across the line indicated in B for a WT (C) and an *mlck-1(RNA1)* (D) cell. Peaks indicate actomyosin bundles. Actin fluorescence peaks have corresponding myosin fluorescence peaks in the WT cell (C) but not in the *mlck-1(RNAi)* cell (D), where myosin fluoresces in uniform. (E) Colocalization analysis of actin and myosin in individual cells. Each point represents the Pearson's *R* value for an individual cell with no more than three cells measured from the same spermatheca; WT, *n* = 17 cells (7 spermathecae); *mlck-1(RNAi), n* = 36 cells (12 spermathecae). Error bars represent SEM. Unpaired *t* test: \*\**p* ≤ 0.01. Scale bar, 5 μm (A) and 20 μm (B).](mbc-29-1975-g008){#F8}

To further explore the effect of *mlck-1* depletion on the distribution of myosin, we imaged GFP::NMY-1 in spermathecal cross-sections and observed a loss of basal myosin localization and an enrichment of myosin at the apical actin network when *mlck-1* is depleted ([Figure 9, A--C](#F9){ref-type="fig"}). Unphosphorylated nonmuscle myosin does not form bipolar filaments ([@B85]) or stably associate with actin ([@B112]). To determine whether the GFP::NMY-1 distribution could be explained by a reduction in the stability of association of myosin with actin, we used fluorescence recovery after photobleaching (FRAP) to quantify myosin dynamics in actomyosin bundles. As has been seen in other systems ([@B112]; [@B50]), depletion of *mlck-1* resulted in enhanced myosin dynamics, increasing the mobile fraction and decreasing the recovery time compared with wild type ([Figure 9, D--G](#F9){ref-type="fig"}). Conversely, increasing myosin activity by knocking down the myosin phosphatase *mel-11* has the opposite effect on myosin dynamics. Depletion of *mel-11* results in the formation of large myosin foci that form transverse bands extending across multiple actin bundles ([@B114]). These myosin foci are highly stable and show little recovery after bleaching ([Figure 9, D--G](#F9){ref-type="fig"}). Overall, these results suggest that MLCK-1 is required for formation of basally enriched actomyosin bundles.

![MLCK-1 is required for stable recruitment of myosin into basal actomyosin bundles. (A) Confocal cross-section of a WT and an *mlck-1(RNAi)* spermathecal cell expressing moeABD::mCherry to label F-actin and GFP::NMY-1 to label myosin. In the WT cell, actin and myosin are primarily at the basal cell surface. In the *mlck-1(RNAi)* cell, basal actomyosin is less prominent and myosin is also enriched at the apical cell surface. (B) Measured myosin fluorescence intensity across the region shown in A. (C) Quantification of apical and basal myosin fluorescence intensity in WT and *mlck-1(RNAi)* cells normalized to the cytosolic myosin fluorescence intensity. Each point represents a measurement taken from a single cell, with only one cell measured per spermatheca; WT, *n* = 9; *mlck-1(RNAi)*, *n* = 11. (D--G) FRAP analysis of myosin dynamics in WT, *mlck-1(RNAi),* and *mel-11(RNAi)* basal actomyosin bundles in spermathecal cells. Basal actomyosin bundles were bleached and recovery was monitored at 1-s intervals for 100 s to calculate the mobile fraction (D) and half recovery time (E). Each point is a measurement from a single cell with no more than three cells measured from the same animal; WT, *n* = 9 cells (7 animals); *mlck-1(RNAi), n* = 13 cells (6 animals); *mel-11(RNAi), n* = 12 cells (6 animals). (F, G) Representative myosin fluorescence recovery curves (F) for the cells shown in G. Unpaired *t* test: ns *p* \> 0.05, \**p* ≤ 0.05, \*\*\*\**p* ≤ 0.0001. Error bars represent SEM. Scale bar 5 μm and 2 μm for the inserts.](mbc-29-1975-g009){#F9}

MLCK-1 and ROCK/LET-502 have distinct expression patterns and roles in spermathecal contractility
-------------------------------------------------------------------------------------------------

Given the importance of the Rho kinase ROCK/LET-502 in activating myosin and regulating tissue contractility, we sought to distinguish the roles of ROCK/LET-502 and MLCK-1 in the spermatheca. We used a line expressing LET-502 labeled at the endogenous locus with GFP using CRISPR to determine the expression pattern of *let-502*. As has been observed previously ([@B115]), LET-502 is only faintly expressed in the spermathecal bag cells and high levels of LET-502 are restricted to the distal neck and sp-ut valve cells ([Figure 10, A and B](#F10){ref-type="fig"}). This is distinct from the expression pattern of MLCK-1, which is seen throughout the spermatheca including the distal neck, main bag cells, and sp-ut valve ([Figures 3B](#F3){ref-type="fig"} and [10, A and B](#F10){ref-type="fig"}).

![MLCK-1 and ROCK/LET-502 have distinct spatial expression patterns and roles in the spermatheca. (A) Anatomy of the spermatheca highlighting differentially regulated cells and *mlck-1* and *let-502* expression patterns. (B) Confocal maximum projections of excised spermathecae stained with phalloidin to visualize F-actin expressing *mlck-1* or *let-502* labeled with mKate2 and GFP, respectively, at the endogenous locus. MLCK-1 is seen throughout the spermatheca, including the distal neck, bag, and valve cells, while LET-502 is prominently expressed only in the distal neck and valve. (C) Animals with depleted *let-502* either through RNAi or the *sb106* allele damage oocytes during entry into the spermatheca, resulting in a larger fraction of the pinched oocytes in the gonad arm. (D) LET-502 is also required for WT dwell time. Loss of *let-502* results in the spermatheca uterine valve opening prior to distal neck closure and thus a negative dwell time. (E) Quantification of p-MRLC in three regions of the spermatheca using a p-MRLC--specific antibody. Each point represents a measurement taken from a single spermatheca; WT distal neck, dorsal bag, and valve, *n* = 17, 16, and 13, respectively; *let-502(sb106);let-502(RNAi)* distal neck, dorsal bag, and valve, *n* = 22, 29, and 24, respectively. (F) Representative confocal maximum intensity projections of the data presented in E. F-actin was stained using phalloidin to detect individual cells. The distal neck (blue), dorsal bag (red), and valve (green) cells are indicated with a dotted outline. Numbers in F indicate average fluorescence intensity of the outlined regions. The distal neck frequently has elevated p-MRLC, which is absent in animals depleted of *let-502*. Unpaired *t* test: ns *p* \> 0.05, \**p* ≤ 0.05, \*\**p* ≤ 0.01, \*\*\**p* ≤ 0.001, \*\*\*\**p* ≤ 0.0001. In C, the unpaired *t* test with Welch's correction was used to account for differences in the SD. Scale bar, 20 μm.](mbc-29-1975-g010){#F10}

To further characterize the role of LET-502 in oocyte entry and transit through the spermatheca, we depleted *let-502* using RNAi and a temperature-sensitive allele, *let-502(sb106*), that has decreased function above 20°C ([@B76]). Embryo transits in wild type, *let-502(RNAi),* and *let-502(sb106)* animals were observed using DIC microscopy. In agreement with previous work ([@B115]; [@B75]), we find that *let-502* is required for oocyte entry, which is driven by sheath cell contraction ([Figure 10, C and D](#F10){ref-type="fig"}). During oocyte entry, sheath cells pull the distal neck of the spermatheca over the incoming oocyte, and the distal neck cells contract to enclose the now-fertilized embryo. In WT animals, this process occurs without damaging the oocyte. In contrast, in *let-502* depleted animals, the distal neck cells close on the incoming oocyte, pinching it in half, allowing part of it into the spermatheca while the other portion remains in the gonad arm ([Figure 10C](#F10){ref-type="fig"}). In WT animals, the embryo remains completely enclosed by the spermatheca for a dwell time of ∼200 s. When *let-502* is disrupted, the sp-ut valve does not remain closed. This results in short dwell times, where, in some cases, the valve opens to allow the oocyte into the uterus before the distal neck cells close (negative values in [Figure 10D](#F10){ref-type="fig"}). These results, in conjunction with the LET-502 expression pattern, suggest that LET-502 is both expressed and functions to regulate the contractility of the distal neck cells and the sp-ut valve.

Because ROCK plays an important role in activating myosin ([@B1]; [@B22]; [@B4]), we used the same immunohistochemistry approach described above to quantify p-MRLC levels in spermathecae from *let-502* depleted animals. In agreement with previous work, we find that *let-502* RNAi produces a mild phenotype ([@B75]) and that the allele produces a stronger loss of function phenotype ([Figure 10, C and D](#F10){ref-type="fig"}). For this reason, we used a combination of *let-502* RNAi in the temperature sensitive background to deplete *let-502* activity. Using this approach, we find that loss of *let-502* does not result in a reduction in p-MRLC levels in the spermathecal bag cells compared with those in WT spermathecal bag cells ([Figure 10, E and F](#F10){ref-type="fig"}). Rather, there is a slight but significant increase in p-MRLC in these cells in *let-502* depleted animals ([Figure 10, E and F](#F10){ref-type="fig"}). This differs from results obtained with *mlck-1(RNAi)* spermathecae where p-MRLC levels were strongly reduced ([Figure 7](#F7){ref-type="fig"}). However, we do find that *let-502* is required for p-MRLC levels in the distal neck. In WT spermathecae, the distal neck cells frequently have elevated p-MRLC levels ([Figure 10, E and F](#F10){ref-type="fig"}). This is abolished by depletion of *let-502* ([Figure 10, E and F](#F10){ref-type="fig"}). Although our results indicate that *let-502* is required for contractility of the valve, we observed low p-MRLC levels in valves from both WT and *let-502* depleted spermathecae ([Figure 10, E and F](#F10){ref-type="fig"}). This may indicate that basal p-MRLC levels are low in the valve so that we are unable to detect further depression upon *let-502* depletion. Alternatively, it is possible that the compact actin structures of the valve preclude efficient antibody penetration. Overall, we find that *let-502* appears to be required for maintaining p-MRLC levels and contractility of the distal neck and valve cells but plays less of a role in the main bag cells, where MLCK-1 is required for production of p-MRLC during contraction.

DISCUSSION
==========

Here we characterize MLCK-1, a *C. elegans* Ca^2+^/CaM--dependent MLCK, and demonstrate its role in spermathecal contractility. We have shown previously that production of Ca^2+^ transients drives contraction ([@B52]) and development of stress fiber--like actomyosin bundles ([@B114]). However, the kinase responsible for increasing myosin activity downstream of Ca^2+^ in the spermatheca was not known. MLCK-1 contains a highly conserved serine/threonine kinase domain, an autoregulatory helix, and a 1-8-14 CaM binding motif characteristic of Ca^2+^/CaM--dependent MLCKs ([@B80]; [@B119]; [@B12]) Animals depleted of MLCK-1 have flaccid spermathecae that fail to contract during ovulation, resulting in trapping of the embryo in the spermatheca. Using immunohistochemistry, we show that this decrease in contractility is due to a reduction in p-MRLC in MLCK-1--depleted spermathecal cells. Depressed spermathecal contractility reduces animal fertility and embryonic viability. The effect on embryonic viability is dependent on the maternal genotype, indicating that it may be due to altered mechanical stress experienced by the embryo during ovulation rather than to defects in embryogenesis. This effect has been reported previously in animals with decreased spermathecal contractility ([@B51]).

MLCK-1 is prominently expressed in the spermatheca. Spermathecal expression is first detected at L4, as the spermatheca is developing, and increases as animals enter adulthood. We find that the subcellular localization of MLCK-1 changes during adulthood when animals begin to ovulate and the spermatheca is exposed to cyclic rounds of stretching and contraction. Prior to the first ovulation, MLCK-1 is found at apical cell boundaries, and after ovulation begins, a small fraction of MLCK-1 colocalizes with basal actomyosin bundles. Basal recruitment of MLCK-1 coincides with the onset of contraction, suggesting that basally recruited MLCK-1 is active and phosphorylating the MRLC in basal actomyosin bundles to drive contraction. This distribution is maintained throughout adulthood. Similarly, work in cell culture has shown that active smMLCK is recruited to contracting actin networks during cell migration ([@B14]) and contraction ([@B106]) and in vivo only a small fraction of the total MLCK is active during contraction ([@B38]; [@B37]). Consistent with this interpretation, we find that depletion of PLC-1 abolishes spermathecal Ca^2+^ signaling during ovulation ([@B52]) and prevents basal MLCK-1 recruitment and actomyosin contraction. However, Ca^2+^ signaling alone does not appear to determine MLCK-1 localization. During ovulation, Ca^2+^ transients peak during contraction and then return to baseline preovulation levels ([@B52]). Interestingly, we see that MLCK-1 is maintained at the basal actomyosin network throughout adulthood, suggesting that there is another mechanism that drives MLCK-1 localization. In addition to regulation by Ca^2+^/CaM, vertebrate MLCK is regulated by phosphorylation ([@B16]; [@B71]; [@B47]; [@B84]; [@B6]; [@B34]), interaction with cytoskeletal proteins ([@B88]; [@B97]; [@B53]; [@B101]), and mechanical stretch ([@B3]). It is unclear whether similar regulatory mechanisms exist for MLCK-1, as MLCK-1 lacks the DXRXXL ([@B61]; [@B97], [@B96]; [@B77]; [@B13]), telokin ([@B93]; [@B72]; [@B31]), and immunoglobulin G (IgG)-C2 ([@B53]) domains that allow smMLCK to interact with actin, myosin, and other cytoskeletal components. However, other vertebrate MLCK isoforms expressed in skeletal and cardiac muscle also lack these conserved domains and yet are found associated with actin ([@B11]) and organized into sarcomeres ([@B10]), indicating that alternative uncharacterized mechanisms for localizing MLCKs at contractile actomyosin structures also exist in vertebrates. While the N-terminus of MLCK-1 contains the highly conserved serine/threonine kinase domain, the C-terminus is poorly conserved, and its function remains unclear.

We have shown previously that parallel actomyosin bundles develop during the first ovulation and are maintained throughout adulthood ([@B114]). Here, we show that MLCK-1 is required for parallel bundle production. Time-lapse microscopy of ovulation shows that loss of MLCK-1 results in persistence of the preovulation actin network characterized by webby, poorly oriented bundles. This phenotype has been described previously for *plc-1--* and *nmy-1*--depleted animals ([@B114]), indicating that the population of MLCK-1 at apical boundaries, retained in *plc-1(RNAi)*, is not responsible for parallel bundle production. In addition to actin, myosin organization is also disrupted, with knockdown of *mlck-1*. In *mlck-1*--depleted cells, myosin is poorly recruited to basal actomyosin bundles. In cultured cells, myosin activity is required for stable association of myosin within actomyosin networks ([@B112]; [@B50]; [@B40]). Our FRAP experiments show that myosin in basal actomyosin bundles is more dynamic in *mlck-1*--depleted than in WT cells. This suggests that localized MLCK-1 activity at the basal actomyosin network is one potential mechanism by which myosin is incorporated into basal actomyosin bundles.

Because ROCK/LET-502 is known to play a role in *C. elegans* somatic gonad contractility ([@B115]; [@B75]) and the formation of stress fibers ([@B1]; [@B22]; [@B4]), we sought to determine the contribution of this kinase to spermathecal function. Here we show that ROCK/LET-502 and MLCK-1 have distinct expression patterns and different roles in regulating spermathecal contraction. In agreement with previous work, we find that ROCK/LET-502 is strongly expressed in the distal neck and valve cells and only weakly in bag cells ([@B115]), while MLCK-1 is expressed throughout the spermatheca. Consistent with the ROCK/LET-502 expression pattern, we find that ROCK/LET-502 is predominantly required for regulating contractility and producing p-MRLC in the distal neck and valve. Unlike depletion of *mlck-1*, knockdown of *let-502* does not decrease p-MRLC levels in spermathecal bag cells. In other systems, ROCK and MLCK play distinct and complementary roles to allow precise spatiotemporal regulation of myosin activity. This is seen in individual cells where MLCK activates myosin in peripheral stress fibers and ROCK is required for formation of central stress fibers ([@B104], [@B103]; [@B94]; [@B4]; [@B43]) and in cell response to stretch ([@B55]), as well as at the tissue level, where MLCK and ROCK cooperate during wound closure ([@B82]). In the spermatheca, ROCK/LET-502 and MLCK cooperate to regulate contractility by acting primarily in a distinct subset of cells. This may have evolved as a mechanism for maintaining different tissue tone in the spermathecal distal neck and valve than in the bag. Tight closure of the spermathecal distal neck during ovulation is needed to prevent the embryo from sliding backward into the proximal gonad arm ([@B25]; McGovern *et al.*, 2018). However, hyperconstriction of the spermathecal bag cells can damage embryos ([@B102]), supporting the idea that distal neck and bag cells constrict to different degrees during ovulation. Our finding that ROCK/LET-502 is primarily required in a specific subset of somatic gonad cells may help explain why defects in somatic gonad contractility have been reported previously with *let-502* depletion ([@B115]; [@B75]) without having a significant impact on actomyosin organization or p-MRLC levels in sheath cells ([@B75]).

Here, we describe a new myosin light-chain kinase, MLCK-1, required for contraction of the spermatheca and show that MLCK-1 and LET-502/ROCK act in distinct subsets of spermathecal cells to coordinate contraction during ovulation. While it is known that ROCK and MLCK share roles in regulating contractility of the gastrointestinal ([@B18]; [@B78]) and urinary tracts ([@B46]) and integrity of the epithelia in airways ([@B74]), the exact molecular mechanism by which these two kinases coregulate MRLC phosphorylation is less well understood. In addition to providing mechanistic insight into how the spermatheca functions, this study helps to establish an in vivo model of how cells coordinate tissue-level responses through the regulation of MLCK and ROCK.

MATERIALS AND METHODS
=====================

*C. elegans* strains and culture
--------------------------------

All stains were grown on standard NGM (0.107 M NaCl, 0.25% wt/vol Peptone \[Fisher Science Education\], 1.7% wt/vol BD Bacto-Agar \[Fisher Scientific\], 0.5% Nyastatin \[Sigma\], 0.1 mM CaCl~2~, 0.1 mM MgSO~4~, 0.5% wt/vol cholesterol, 2.5 mM KPO~4~) agar plates seeded with OP50 *Escherichia coli* at 23°C ([@B32]) unless otherwise noted. Strains were generated by microinjection as described previously ([@B67]). The *mlck-1p::GFP::unc-54 3′UTR* reporter construct was injected at 20 ng/μl with the coinjection marker, *rol-6*, injected at 40 ng/μl. Lines expressing GFP::*act-1* and moeABD::mCherry;GFP::*nmy-1* were described previously ([@B114]). The MLCK-1 allele, *mlck-1(tm4159)*, was obtained from the Japanese National Bioresource Project and outcrossed three times to WT worms to create the strain UN1604*.* The *let-502(sb106)* allele was previously described in ([@B76]). The endogenously tagged strains, COP1510 *mlck-1::degron::mKate2* and COP1226 *let-502::degron::eGFP* endogenously tagged with GFP strain, were generated by Nemametrix. COP1510 was outcrossed three times to create the strain UN1743. The strain was generated by crossing NK1069 with EU573. EU573 has been described previously ([@B22]). See Supplemental Table 1 for a list of strains and genotypes used in these experiments.

RNAi interference
-----------------

RNAi feeding experiments were performed essentially as described previously ([@B51]). To prepare seeded NGM-IPTG plates, HT115(DE3) bacteria transformed with the double-stranded RNA construct of interest were grown overnight at 37°C in Luria broth (LB) supplemented with 40 µg/ml ampicillin. The following day, 150 µl of the culture was seeded on NGM-IPTG agar (NGM supplemented with 25 µg/ml carbenicillin and 1 mM isopropylthio-β-galactoside, IPTG). Synchronized populations were obtained by alkaline lysis procedure (egg prep). For egg prep, starved dauer nematodes were allowed to recover for 48 h on NGM plates newly seeded with OP50. This produces young gravid adults for egg collection. Eggs were released using an alkaline hypochlorite solution as described in [@B32] and washed three times with filtered sterilized M9 buffer (22 mM KH~2~PO~4~, 42 mM NaHPO~4~, 86 mM NaCl, and 1 mM MgSO~4~; [@B32]). Clean eggs were then transferred to seeded NGM-IPTG plates. Animals were allowed to grow for ∼54 h at 23°C before being scored or imaged unless otherwise noted. Several of the RNAi constructs used were from the ORF-eome-RNAi v1.1 or the Ahringer Library. Some RNAi constructs were made by amplifying the coding region of the gene of interest off of mixed age N2 cDNA and cloning them into the empty vector pPD129.36 (Fire Vector Kit). Primers used to clone RNAi are available upon request. The empty vector was used as a negative control in all RNAi experiments.

Spermathecal occupancy assay
----------------------------

Synchronized populations obtained by egg prep, described above, were grown on NGM-IPTG plates with the indicated RNAi treatment, and worms were scored ∼54 h after egg prep when they were just beginning to ovulate. Worms were mounted on a 2% agarose--in--water pad and killed using 100 mM sodium azide. Scoring for occupancy of spermathecae was done using a 60× oil-immersion objective with a Nikon Eclipse 80i microscope.

Protein alignments
------------------

Kinase domains used in the alignments were identified using SMART ([@B86]; [@B57], [@B58]; [@B56]) and aligned using Clustal Omega ([@B92]; [@B66]; [@B60]). The 3D protein structures were predicted using iTasser ([@B121]; [@B81]; [@B118]). The 3D structures were rotated, and residues were colored using the PyMol Molecular Graphics System (Version 1.74, Schrödinger). Calmodulin binding domains were identified using the Calmodulin Target Database ([@B119]), aligned using Clustal Omega ([@B92]; [@B66]; [@B60]), and made ready for publication using BoxShade.

Determination of number of live hatchlings
------------------------------------------

Embryos were egg-prepped onto an NGM plate seeded with OP50. The animals were grown at 23°C, unless otherwise noted, and at L4, animals were transferred to individual plates. Total live hatchlings were counted and aspirated every day until the mother died or there were two consecutive days of no new hatchlings on the plate.

Viability assay
---------------

Synchronized populations obtained by egg prep, described above, were grown on NGM at 23°C for ∼60 h. Worms were then moved to individual plates for 2-4 h and allowed to lay embryos on the plates. Hermaphrodites were removed, and all embryos laid were counted before incubation at 23°C for 24 h. Plates were scored for the number of worms that hatched from embryos (viable) and embryos that failed to hatch (not viable).

DIC imaging
-----------

Animals were immobilized either with 0.01% tetramisole and 0.1% tricaine in M9 buffer or with 0.05 μm Polybead microspheres diluted 1:1:1 in M9 and water on a 2% agarose pad. Imaging was performed on a Nikon Eclipse 80i microscope with a 60× oil-immersion lens using SPOT R3 software and a charge-coupled device camera. Frames were captured at a rate of 1 Hz. Image stacks were reassembled and analyzed using ImageJ software. To be considered "trapped," worms were imaged for at least 950 s after entry. Raw dwell times for worms treated with *mlck-1* RNAi can be found in Supplemental Figure 6.

Histochemistry
--------------

Visualization of F-actin in animals expressing MLCK-1 labeled with mKate2 or LET-502 labeled with GFP was done as described previously ([@B114]) except that 100 nM Acti-stain 488 (Cytoskeleton \#PHDG1) was used in place of Texas Red-X phalloidin (Invitrogen) to allow simultaneous visualization of F-actin and mKate2. For quantification of p-MRLC, synchronized populations were obtained by egg prep and grown with the indicated RNAi treatment at 23°C for ∼54 h. Fixation and staining protocols were adapted from ([@B113]; [@B75]). Unless noted, all steps were done at room temperature. Animals were dissected using a 25-gauge hypodermic needle in phosphate-buffered saline (PBS), and dissected gonads were fixed with 4% formaldehyde and 0.2% glutaraldehyde in cytoskeleton buffer (10 mM MES pH 6.1, 138 mM KCl, 3 mM MgCl~2~, 10 mM ethylene glycol-bis(β-aminoethyl ether)-**N**,**N**,**N**,**N**-tetraacetic acid \[EGTA\], and 0.32 M sucrose) for 10 min. Fixative was removed by three washes with PBS and unreacted aldehydes were quenched by incubation in 0.1% sodium borohydride in PBS for 20 min. Quenching was followed by two PBS rinses before permeabilization with 0.25% Triton X-100 in PBS for 10 min. After three PBS rinses, dissected gonads were blocked in 1% BSA, 0.1% Tween-20, and 30 mM glycine in PBS for 1 h before addition of the primary antibody, anti-myosin light-chain (phospho S20) antibody (Abcam \#ab2480), at 2.5 µg/ml in blocking buffer. Incubation with the primary was done overnight at 4°C followed by three PBS washes and incubation with the secondary, donkey anti-rabbit IgG H&L (DyLight 488) preadsorbed (Abcam \#ab96919) diluted 1:1000 in blocking buffer, for 6 h at room temperature. After 6 h, 0.4 U/mL Texas Red-X phalloidin in PBS (InvitrogenA) was added, followed by incubation overnight at 4°C. Dissected gonads were washed three times in PBS and mounted in 90% glycerol, 20 mM Tris, pH 8.3, on 2% agarose pads.

Confocal microscopy
-------------------

For time-lapse imaging of ovulation and observations of live or fixed animals, partially synchronized populations were obtained by egg prep and animals were grown at 23°C for ∼54 h, around the time of the first ovulation. Live animals were immobilized with 0.01% tetramisole and 0.1% tricaine in M9 buffer ([@B45]; [@B63]) and mounted on 2% agarose pads or with 0.05 μm Polybead microspheres (Polysciences) diluted 1:2 in water and mounted on 5% agarose pads ([@B110]). Confocal microscopy was performed on an LSM 710 confocal microscope (Zeiss) equipped with Zen software (Zeiss) using a Plan-Apochromat 63×/1.40 oil DIC M27 objective. A 488-nm laser was used for GFP and DyLight 488, and a 561 nm laser was used for mKate2 and TexasRed. For movies, 40 or 20 z-slices were acquired at 14- or 10-s intervals for imaging actin labeled with GFP and MLCK-1 labeled with mKate2, respectively. Illumination of the spermathecae from animals expressing actin labeled with GFP (GFP::ACT-1) with the 488-nm laser for ∼5 min prior to oocyte entry frequently caused the valve to remain partially closed during ovulation, increasing oocyte dwell time. Live animals were imaged for ∼ 30 min total. For still images of live and fixed animals and tissue, z-slices were acquired at 0.38-μm intervals, with each slice representing the average of two or four scans.

FRAP
----

Live animals grown at 23°C for ∼54 h were immobilized as described above. Confocal microscopy was performed on an LSM 710 confocal microscope (Zeiss) equipped with Zen software (Zeiss) using the 63× oil objective and the 488-nm laser. Five confocal sections of the basal cell surface were acquired at 1-s intervals prior to the bleaching step to measure the starting fluorescence intensity, 10 bleaching scans were preformed using the 488-nm laser at 100% with a pixel dwell time of 0.95 μs in a 9 by 1.5--μm region across the center of the cell, and 95 images were acquired at 1-s intervals to monitor fluorescence recovery after bleaching. Analysis of FRAP data was done using a Jython script in ImageJ. This script allows selection of a bleached area, the 9 by 1.5--μm region, and a region outside of the bleached area. A region within this same cell was used. This nonbleached region is used to normalize measurements to account for photobleaching. With this experimental setup, however, we did not detect photobleaching of GFP.

Image analysis
--------------

ImageJ software was used for all image analysis. Unless otherwise noted, all images were background-subtracted prior to analysis. For consistency, all analysis was performed on cells of the main spermathecal bag, unless otherwise noted. For analysis of MLCK-1 dynamics during ovulation, MLCK-1::mKate2 fluorescence was measured from confocal maximum intensity projections of ovulation movies at 50- s intervals. For each measurement, a 20 pixel--wide line was drawn across one cell. The BAR script Find Peaks was used to detect the bright MLCK-1::mKate2 signal at the cell edges. The average distance between the peaks was used to find the cell center and 10 pixels above and below this central point were measured for the MLCK-1::mKate2 fluorescence signal, excluding the cell edges. For analysis of MLCK-1 distribution in fixed samples, a 100 pixel--wide line was drawn across a single sagittal confocal cross-section and the BAR script Find Peaks was used to determine fluorescence intensity at the basal cell surface. To measure p-MRLC intensities, maximum-intensity projections were generated and F-actin staining was used to distinguish individual cells. Individual cells were outlined and fluorescence intensity in the 488-nm channel corresponding to p-MRLC was measured. This same strategy was used to quantify p-MRLC in [Figure 10](#F10){ref-type="fig"}, except that specific regions of the spermatheca were selected rather than individual cells. For measurements of actin network organization, FibrilTool ([@B8]) was used to quantify actin anisotropy in selected cells. For movie analysis, maximum-intensity projections were generated and FibrilTool was used on individual cells at 28 s intervals (every other frame). Anisotropy measurements were normalized by taking the average anisotropy of the first 10 frames measured and subtracting this number from each measurement. OrientationJ ([@B79]), configured using a Gaussian fit with a pixel size of 2, was used to measure the orientation distribution of actin bundles in individual cells and to generate color-coded images where color indicates orientation, hue indicates coherency, and brightness is the brightness of the original image. To determine actin and myosin distribution, a line with a pixel width of 10 was drawn across indicated cells to measure actin and myosin fluorescence intensity. For colocalization analysis, the ImageJ plug-in Coloc2 was used to measure the Pearson's *R* value of selected cells. To measure the apical and basal distribution of GFP-labeled myosin, a 20 pixel--wide line was drawn across a single sagittal cross-section. The BAR script Find Peaks was used to detect bright GFP signals at the basal and apical cell surfaces. In spermathecae of WT animals, if the apical GFP signal was not above background and no peak was detected, the apical surface was determined manually. The average distance between the apical and basal peaks was used to find the center of the cell. The average of five pixels above and below this central point was measured for the cytosolic GFP signal, to which the apical and basal measurements were normalized.

Statistical analysis
--------------------

All statistical analysis was performed with GraphPad Prism software. To compare two unpaired groups, the unpaired *t* test was used to determine whether the difference between the means of two data sets was significant when data had a normal distribution, and Welch's correction was included if the different treatments were expected to have different standard deviations. To compare three or more unmatched groups, ordinary one-way analysis of variance (ANOVA) was performed with either a Dunnett's multiple comparison or a Tukey's multiple comparison test as necessary. The Mann--Whitney test was used when data did not have a normal distribution. All trapping data were analyzed using Fisher's exact test. In all cases, the statistical test used and the resulting *p* values, indicated by symbols as ns (*p* \> 0.05), \*(*p* ≤ 0.05), \*\*(*p* ≤ 0.01), \*\*\*(*p* ≤ 0.001), and \*\*\*\*(*p* ≤ 0.0001), are noted in each figure caption.
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CaM

:   calmodulin

F-actin

:   filamentous-actin

GFP

:   green fluorescent protein

MLCK

:   myosin light-chain kinase

MRLC

:   myosin regulatory light chain

MYPT

:   myosin phosphatase

NMII

:   nonmuscle myosin II

pMRLC

:   phosphorylated myosin regulatory light chain

RNAi

:   RNA interference

ROCK

:   Rho kinase

sp-ut

:   spermatheca--uterine.
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